NCT00484263View on ClinicalTrials.gov

The Long Term Effect of Inhaled Hypertonic Saline (6%) in Patients With Non Cystic Fibrosis Bronchiectasis

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Bronchiectasis
Interventions
DRUG

Hypertonic saline 6% -

Hypertonic saline (6%) - 5mls twice a day via a nebuliser for 12 months

Trial Locations (1)

3126

The Alfred Hospital, Melbourne

All Listed Sponsors
lead

The Alfred

OTHER

NCT00484263 - The Long Term Effect of Inhaled Hypertonic Saline (6%) in Patients With Non Cystic Fibrosis Bronchiectasis | Biotech Hunter | Biotech Hunter